SHARE
COPY LINK

HEALTH

Burnout on the rise among Swiss doctors

Almost 200 doctors sought help due to stress, anxiety and self-doubt in Switzerland last year – this figure is double that seen six years ago.

geneva university hospital
File photo of Geneva University Hospital (HUG) from 2014. Hospital doctors have struggled with a massive increase in workload as result of the pandemic. Photo: FABRICE COFFRINI / AFP

Professional exhaustion in the medical profession is on the rise, a spokesperson from the Federation of Swiss Doctors (FMH) told Swiss newspaper NZZ am Sonntag.

The Covid-19 pandemic significantly increased doctors’ workloads last year, particularly for those who work in hospitals.

More than half of the 1,500 doctors surveyed in a FMH poll this week reported that they “usually or frequently” experienced stress over the last year.

Some said they felt they could no longer meet the requirements of the job.

But the amount of work they have to do isn’t the only reason for the increase in burnout, which is around twice as common in doctors compared to other professionals.

A shortage of qualified staff is also contributing to the rising exhaustion rates, with hospitals struggling to fill empty posts.

This is particularly bad in rural areas where some establishments receive hardly any applications for vacant position.

Some clinics have to wait for months before they can hire someone and, in the meantime, other staff have to take on the extra work, irrespective of how heavy their workload is already.

According to VSAO, the Swiss Association of Junior and Senior Physicians, every second junior doctor is on duty longer than the 50 hours permitted each week.

And two out of every three doctors work more than the law allows.

It’s not surprising, therefore, that in 2021, a total of 189 doctors sought help from support network for doctors in crisis Remed, due to anxiety, depression, self-doubt or overwhelming workloads.This number has almost doubled since 2015.

Two out of every three of those calls were made by female doctors.

These are often conscientious, competent and sensitive women who are exhausted by their dual role of mother and doctor, ReMed psychiatrist Mirjam Tanner explained to the German-speaking newspaper.

They expressed admiration for colleagues who seemed to get things done so easily while they themselves felt incapable of being a good doctor.

But Tanner explained that just because male doctors were less likely to ask for help, that did not necessarily mean they were coping better, simply that they have a higher inhibition threshold when it comes to seeking advice.

Nor did the psychiatrist expect calls for help to decrease, noting that more people were aware of the ReMed service now and that more people were open to getting support.

And what about a solution? The FMH spokesperson said the only way out of the situation in the short term would be to reduce capacity – ie to close beds or even entire departments.

Longer term, they are calling for more doctors to be trained.

READ ALSO:

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Which medications in Switzerland are set to become more expensive?

The cost of medications in Switzerland is already quite a bit higher than elsewhere in Europe. And now certain drugs will become even pricier.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries. 

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023. 

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin. 

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland. 

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more  for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

SHOW COMMENTS